- Gus Cairns | 24 August 2012
Several research papers published in the last month have reported strong correlations between specific immune
responses and protection against HIV infection or its effects. These include a
comparison of women in the ...
- Gus Cairns | 10 August 2012
HIV experts are concerned
that the largely Islamic countries of the middle east and north Africa may be set to
follow east and south-east Asia in seeing sharp rises in HIV infections ...
- Gus Cairns | 10 August 2012
A large, randomised sample of 21-year-old
Thai men, presented at the 19th International AIDS Conference in Washington recently, has found that by far the largest risk factor for HIV infection is
gay ...
- Carole Leach-Lemens | 09 August 2012
Complications
of HIV infection among adolescents in resource-poor settings
include malnutrition, chronic lung disease and tuberculosis as well as the
long-term side effects of drugs - including
lipodystrophy, peripheral neuropathy and high blood cholesterol
(dislypidemia) ...
- Gus Cairns | 08 August 2012
A new study
presented at the 19th
International AIDS Conference shows that young people, African Americans,
and heterosexual men have particularly low rates of retention in care and viral
suppression and that there are ...
- Gus Cairns | 06 August 2012
A number of presentations at the 19th International AIDS Conference explored
the 'hyperepidemic' of HIV amongst men who have sex with men, and especially
black MSM. A
paper presented by Gregorio Millet showed ...
- Roger Pebody | 03 August 2012
A study which aimed to produce a definition of intimate
partner violence (physical, sexual, or psychological harm caused by a current
or former partner) that would be appropriate for gay, bisexual and ...
- Kelly Safreed-Harmon | 02 August 2012
Studies
presented at the Nineteenth International AIDS Conference (AIDS 2012) in Washington DC
called attention to the benefits of increasing male involvement in prevention
of mother-to-child transmission (PMTCT) efforts. Most notably, a Tanzanian
study ...
- Kelly Safreed-Harmon | 02 August 2012
Research from Malawi further strengthens the case for using
infant immunisation clinics as a key site for maternal and early infant HIV diagnosis, the Nineteenth
International AIDS Conference (AIDS 2012) heard last ...
- Carole Leach-Lemens | 02 August 2012
A higher CD4 cell count benefits the household economically
and is associated with better educational opportunities for the children in the
household, according to findings from a study in Uganda
presented last week ...
- Mara Kardas-Nelson | 02 August 2012
Stemming in part
from negative associations with the virus itself, and in part from marginalisation
of populations highly impacted by the virus, stigma and discrimination has
long dissuaded people from accessing HIV-related services. ...
- Mara Kardas-Nelson | 01 August 2012
HIV infections
among drug users currently make up 30% of new infections globally. Their social
marginalisation makes them an especially difficult group to target for public
health and HIV interventions. Yet researchers, civil ...
- Roger Pebody | 01 August 2012
In the last few years there has been a wealth of dramatic
data on the efficacy of new HIV prevention methods, including male
circumcision, pre-exposure prophylaxis and treatment as prevention. While last
week’s ...
- Mara Kardas-Nelson | 31 July 2012
Cash transfers
to orphans and vulnerable children in Kenya
are associated with later onset of sexual activity and fewer sexual partners,
but no increase in condom use among those already sexually active, according ...
- Lesley Odendal | 31 July 2012
BCG vaccination, routinely given at birth
to protect from tuberculosis (TB), causes an immune-activation of CD4 T cells,
the HIV target cells, according to a South African study presented at the
Nineteenth International ...
- Lesley Odendal | 31 July 2012
Raltegravir seems to be a suitable alternative
to efavirenz for HIV-TB co-infected patients while receiving TB treatment,
according to 24-week results of the ANRS 12 180 REFLATE study presented at the
Nineteenth International ...
- Roger Pebody | 31 July 2012
Although researchers and public health organisations in most
low and middle income countries have not collected any recent data on the
prevalence of HIV in female sex workers, the data that do ...
- Liz Highleyman | 31 July 2012
The
investigational HIV integrase inhibitor elvitegravir taken once daily continued
to perform as well as twice-daily raltegravir (Isentress) at 96 weeks for treatment-experienced people with
extensive drug resistance, according to data presented last
week ...
- Liz Highleyman | 30 July 2012
The new
boosting agent cobicistat works as well as ritonavir (Norvir) as a pharmaco-enhancer or booster for the first-line protease
inhibitor atazanavir (Reyataz) at 48
weeks, according to a report presented last week ...
- Roger Pebody | 30 July 2012
A new analysis of existing studies on the sexual health of
black gay men in the UK has found that despite having similar sexual
risk behaviours to white gay men, they have ...
Antiretroviral drug chartA one-page reference guide to the anti-HIV drugs licensed for use in the UK or European Union, with information on formulation, dosing, key side effects and food requirements.
Your next stepsA booklet with information for people who’ve just found
out they have HIV.
Coming soon: news from IAS 2019 05 July 2019The 10th International AIDS Society
conference (IAS 2019) is being held...
Those who are not seen are not heard 01 July 2019A commentary on Optimising the Impact of Key Population Programming...
The fight for access to abortion care in Europe 27 June 2019Access to
sexual and reproductive health and rights includes safe and...